Expert Connection Program

NoAb BioDiscoveries is committed to providing high-quality drug discovery services to our clients. For over 10 years, clients have relied on our expertise in DMPK services to advance their drug discovery programs. As the landscape of drug discovery research continues to evolve and become exceedingly complex, it is now more than ever critical for researchers to be able to design and develop a proficient discovery program and support the various types of studies needed to ultimately register a novel therapeutic. To that end, NoAb BioDiscoveries has created the Expert Partnership Program, which provides our clients access to the professional services and expertise available through our affiliates.

Expert Partners

Para

Grace M. Furman, Ph.D., D.A.B.T.
President/CEO
P:(760) 271-2858
Paracelsus.inc@cox.net
www.ParacelsusConsulting.com

Grace is a board certified toxicologist with a Ph.D. in Biomedical Sciences specializing in Toxicology. She has almost 20 years of experience in the field, making the decision to become an independent consultant in mid-2006, at which time she was Senior Director of Regulatory Safety Assessment in Pfizer’s Drug Safety Research and Development department. Below is a summary of her service offerings.

Scientific and Strategic Nonclinical Drug Development

  • Nonclinical (toxicology, PK/ADME, pharmacology) program design, protocol development and study monitoring
  • Review and interpretation of
    nonclinical data

Regulatory Document Preparation and Review

  • Preparation of nonclinical components of pre-IND packages, INDs, IMPDs, NDAs
  • Expert review of draft regulatory submissions identifying areas of vulnerability

Regulatory Meeting and Communication Support

  • Meeting preparation and representation at FDAindustry meetings.
  • Preparation of responses to FDA Pharm/Tox queries
 
Phrama

Christopher J. Kemper, Ph.D.
Principal
P:(609) 213-3038
Chris_Kemper@pharmanavigatorsllc.com
www.pharmanavigatorsllc.com

Chris is an expert in Drug Metabolism and Pharmacokinetics and holds a Ph.D. in Pharmacology. With over 25 years of experience in drug discovery with both multinational pharmaceutical companies and CROs, his unique combination of scientific expertise, and business acumen makes him a versatile and valuable addition to drug discovery teams. Below is a summary of his service offerings.

Integrating Disparate Resources in Nonclinical Drug Development

  • Development team support including study recommendations and coordination
    of resources

Providing Strategic and Tactical Approaches to Nonclinical Drug Development

  • Discovery PK, Bioanalysis, In Vivo and In Vitro Models, Constraint Based Management

Documentation Review

  • Interpretation and evaluation of data, IND and NDA Submissions

Presentations on DMPK, Bioanalytical and Laboratory Operation Topics